Results 121 to 130 of about 17,357,527 (148)

Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers. [PDF]

Proc Natl Acad Sci U S A, 2018
Kawakami M, Mustachio LM, Zheng L, Chen Y, Rodriguez-Canales J, Mino B, Kurie JM, Roszik J, Villalobos PA, Thu KL, Silvester J, Cescon DW, Wistuba II, Mak TW, Liu X, Dmitrovsky E.   +15 more
europepmc   +1 more source

Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway. [PDF]

Cell Death Dis, 2018
Tian X, Zhou D, Chen L, Tian Y, Zhong B, Cao Y, Dong Q, Zhou M, Yan J, Wang Y, Qiu Y, Zhang L, Li Z, Wang H, Wang D, Ying G, Zhao Q.   +16 more
europepmc   +1 more source

Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.

J Clin Lab Anal, 2020
Zhou Q, Fan G, Dong Y.
europepmc   +1 more source

Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. [PDF]

Mol Biol Cell, 2018
Boese CJ, Nye J, Buster DW, McLamarrah TA, Byrnes AE, Slep KC, Rusan NM, Rogers GC.   +7 more
europepmc   +1 more source

Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. [PDF]

Oncotarget, 2017
Sredni ST, Bailey AW, Suri A, Hashizume R, He X, Louis N, Gokirmak T, Piper DR, Watterson DM, Tomita T.   +9 more
europepmc   +1 more source

Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4. [PDF]

Science, 2015
Wong YL, Anzola JV, Davis RL, Yoon M, Motamedi A, Kroll A, Seo CP, Hsia JE, Kim SK, Mitchell JW, Mitchell BJ, Desai A, Gahman TC, Shiau AK, Oegema K.   +14 more
europepmc   +1 more source

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. [PDF]

Oncotarget, 2017
Lohse I, Mason J, Cao PM, Pintilie M, Bray M, Hedley DW.   +5 more
europepmc   +1 more source

NFκB regulates expression of Polo-like kinase 4. [PDF]

Cell Cycle, 2013
Ledoux AC, Sellier H, Gillies K, Iannetti A, James J, Perkins ND.   +5 more
europepmc   +1 more source

Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy. [PDF]

J Cancer, 2016
Li Z, Dai K, Wang C, Song Y, Gu F, Liu F, Fu L.   +6 more
europepmc   +1 more source